Prebiotic supplementation in patients with type 1 diabetes: study protocol for a randomised controlled trial in Canada

Introduction Type 1 diabetes (T1D) mellitus is caused by autoimmune destruction of insulin-producing beta-cells, requiring exogenous insulin to sustain life. Achieving near normal blood glucose levels with insulin, a primary goal of diabetes management, carries a significant risk of hypoglycaemia. T...

Полное описание

Библиографические подробности

Главные авторы:	Shyamchand Mayengbam, Raylene A Reimer, Sonia Butalia, Carol Huang, Elizabeth Rosolowsky, Munier A Nour, Josephine Ho, Weilan Wang, Shannon Pyke, Heidi Virtanen
Формат:	Artigo
Язык:	Inglês
Опубликовано:	BMJ Publishing Group 2025-05-01
Серии:	BMJ Open
Online-ссылка:	https://bmjopen.bmj.com/content/15/5/e102486.full
Метки:	Добавить метку Нет меток, Требуется 1-ая метка записи!